Baillie Gifford — ALNY Trade History
Quarter-by-quarter changes in the Alnylam Pharmaceuticals position · CUSIP 02043Q107
Currently held · >10 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-06 | Reduce | 2,439,889 | -53,977 | -2.2% | $734.5M | 0.67% |
| 2026 Q1 | 2026-05-08 | Reduce | 2,493,866 | -107,113 | -4.1% | $825.1M | 0.84% |
| 2025 Q4 | 2026-01-23 | Reduce | 2,600,979 | -188,377 | -6.8% | $1.03B | 0.86% |
| 2025 Q3 | 2025-10-31 | Reduce | 2,789,356 | -242,535 | -8.0% | $1.27B | 0.94% |
| 2025 Q2 | 2025-08-06 | Reduce | 3,031,891 | -625,716 | -17.1% | $988.7M | 0.74% |
| 2025 Q1 | 2025-05-07 | Reduce | 3,657,607 | -382,652 | -9.5% | $987.6M | 0.86% |
| 2024 Q4 | 2025-01-31 | Reduce | 4,040,259 | -846,741 | -17.3% | $950.7M | 0.73% |
| 2024 Q3 | 2024-11-05 | Reduce | 4,887,000 | -1,145,656 | -19.0% | $1.34B | 1.01% |
| 2024 Q2 | 2024-07-25 | Reduce | 6,032,656 | -590,921 | -8.9% | $1.47B | 1.14% |
| 2024 Q1 | 2024-05-01 | Reduce | 6,623,577 | -343,520 | -4.9% | $989.9M | 0.77% |
| 2023 Q4 | 2024-01-26 | Reduce | 6,967,097 | -1,196,042 | -14.7% | $1.33B | 1.06% |
| 2023 Q3 | 2023-11-13 | Reduce | 8,163,139 | -229,077 | -2.7% | $1.45B | 1.32% |
| 2023 Q2 | 2023-07-28 | Reduce | 8,392,216 | -246,925 | -2.9% | $1.59B | 1.35% |
| 2023 Q1 | 2023-05-03 | Reduce | 8,639,141 | -768,730 | -8.2% | $1.73B | 1.56% |
| 2022 Q4 | 2023-03-10 | Reduce | 9,407,871 | -106,887 | -1.1% | $2.24B | 2.33% |
| 2022 Q3 | 2022-10-27 | Reduce | 9,514,758 | -453,676 | -4.6% | $1.90B | 1.96% |
| 2022 Q2 | 2022-08-08 | Reduce | 9,968,434 | -171,295 | -1.7% | $1.45B | 1.49% |
| 2022 Q1 | 2022-05-05 | Reduce | 10,139,729 | -477,022 | -4.5% | $1.66B | 1.16% |
| 2021 Q4 | 2022-01-20 | Add | 10,616,751 | 200,967 | +1.9% | $1.80B | 0.99% |
| 2021 Q3 | 2021-10-19 | Add | 10,415,784 | 190,925 | +1.9% | $1.97B | 1.03% |
| 2021 Q2 | 2021-08-02 | Add | 10,224,859 | 149,896 | +1.5% | $1.73B | 0.84% |
| 2021 Q1 | 2021-05-06 | Add | 10,074,963 | 942,541 | +10.3% | $1.42B | 0.80% |
| 2020 Q4 | 2021-02-10 | Add | 9,132,422 | 240,934 | +2.7% | $1.19B | 0.66% |
| 2020 Q3 | 2020-11-12 | Add | 8,891,488 | 242,810 | +2.8% | $1.29B | 0.89% |
| 2020 Q2 | 2020-08-12 | Add | 8,648,678 | 236,909 | +2.8% | $1.28B | 0.98% |
| 2020 Q1 | 2020-05-08 | Add | 8,411,769 | 225,046 | +2.7% | $915.6M | 0.99% |
| 2019 Q4 | 2020-02-10 | Reduce | 8,186,723 | -49,251 | -0.6% | $942.9M | 0.91% |
| 2019 Q3 | 2019-11-07 | Add | 8,235,974 | 2,022,504 | +32.6% | $662.3M | 0.75% |
| 2019 Q2 | 2019-08-08 | Add | 6,213,470 | 528,966 | +9.3% | $450.9M | 0.48% |
| 2019 Q1 | 2019-05-01 | Add | 5,684,504 | 937,654 | +19.8% | $531.2M | 0.58% |
| 2018 Q4 | 2019-02-14 | Add | 4,746,850 | 284,024 | +6.4% | $346.1M | 0.45% |
| 2018 Q3 | 2018-11-13 | Add | 4,462,826 | 230,945 | +5.5% | $390.6M | 0.42% |
| 2018 Q2 | 2018-07-17 | Add | 4,231,881 | 397,668 | +10.4% | $416.8M | 0.45% |
| 2018 Q1 | 2018-05-10 | Add | 3,834,213 | 223,199 | +6.2% | $456.7M | 0.54% |
| 2017 Q4 | 2018-02-13 | Add | 3,611,014 | 205,622 | +6.0% | $458.8M | 0.57% |
| 2017 Q3 | 2017-10-20 | Reduce | 3,405,392 | -25,924 | -0.8% | $400.1M | 0.51% |
| 2017 Q2 | 2017-08-10 | Add | 3,431,316 | 96,805 | +2.9% | $273.7M | 0.37% |
| 2017 Q1 | 2017-05-12 | Add | 3,334,511 | 16,489 | +0.5% | $170.9M | 0.25% |
| 2016 Q4 | 2017-02-14 | Reduce | 3,318,022 | -50,303 | -1.5% | $124.2M | 0.20% |
| 2016 Q3 | 2016-11-09 | New | 3,368,325 | 3,368,325 | — | $228.3M | 0.36% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.